Clinical Trial Update: TurboPower + DCB Treatment of Femoropopliteal De Novo/ Restenotic and In-Stent Restenosis Lesions

View source ↗

Summary

Clinical trial update for TurboPower with DCB in femoropopliteal lesions (de novo, restenotic, and in-stent restenosis) in peripheral arterial disease; study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• TurboPower

Snippet

Sponsor: Spectranetics Corporation | Conditions: Peripheral Arterial Disease | Status: COMPLETED | Results posted: 2019-04-08